Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Appointed director
CC transcript
Inv. presentation
VIROPHARMA INC (VPHM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/31/2013 8-K Quarterly results
08/01/2013 8-K Quarterly results
Docs: "VIROPHARMA Announces Second Quarter 2013 Financial Results",
"VIROPHARMA PROVIDES UPDATE ON PHASE 2 CLINICAL EVALUATION OF SUBCUTANEOUS CINRYZE®"
10/25/2012 8-K Quarterly results
Docs: "VIROPHARMA Incorporated Reports Third Quarter 2012 Financial Results - Quarter Highlighted by Record U.S. Cinryze ® Net Sales of $83.7M; Company Reiterates Cinryze U.S. Net Sales Guidance -"
08/09/2012 8-K Quarterly results
Docs: "VIROPHARMA Incorporated Reports Second Quarter 2012 Financial Results - Increases 2012 U.S. Cinryze ® Net Product Sales Guidance to between $320 and $335 Million -"
05/01/2012 8-K Quarterly results
Docs: "VIROPHARMA Incorporated Reports First Quarter 2012 Financial Results"
10/27/2011 8-K Quarterly results
Docs: "VIROPHARMA Incorporated Reports Third Quarter 2011 Financial Results - Quarter Highlighted by Record Net Product Sales, European Launch of Cinryze ® and European Approval of Buccolam ® -"
07/28/2011 8-K Form 8-K - Current report
04/28/2011 8-K Form 8-K - Current report
10/27/2010 8-K Form 8-K - Current report
07/28/2010 8-K Form 8-K - Current report
04/28/2010 8-K Quarterly results
Docs: "VIROPHARMA Incorporated Reports First Quarter 2010 Financial Results - Record Total Net Product Sales Up 51 Percent over First Quarter 2009 - - Quarter Highlighted by Manufacturing, European and Clinical Momentum with Cinryze™ -"
10/28/2009 8-K Form 8-K - Current report
07/29/2009 8-K Form 8-K -- Current report
04/29/2009 8-K Form 8-K -- Current report
02/24/2009 8-K Quarterly results
Docs: "VIROPHARMA INCORPORATED Reports Fourth Quarter and Full Year 2008 Financial Results - Quarter Highlighted by Cinryze™ [C1 Inhibitor ] Commercial Launch -"
10/29/2008 8-K Quarterly results
Docs: "VIROPHARMA INCORPORATED Reports Third Quarter 2008 Financial Results - Quarter Highlighted by Record Vancocin Sales and Increase to Net Sales Guidance -"
07/30/2008 8-K Quarterly results
Docs: "VIROPHARMA INCORPORATED Reports Second Quarter 2008 Financial Results - Company Achieves Record Vancocin Net Sales; Increases Full Year Guidance for 2008 -"
04/30/2008 8-K Quarterly results
Docs: "VIROPHARMA INCORPORATED Reports First Quarter 2008 Financial Results"
05/02/2007 8-K Quarterly results
Docs: "VIROPHARMA INCORPORATED Reports First Quarter 2007 Financial Results",
"VIROPHARMA ANNOUNCES DECISION TO DEVELOP AND COMMERCIALIZE MARIBAVIR IN EUROPE - Company Establishing European Subsidiary to Execute Regulatory and Commercialization Strategy -"
05/04/2006 8-K Quarterly results
Docs: "VIROPHARMA INCORPORATED Reports First Quarter 2006 Financial Results and Reiterates Full Year Vancocin Sales Guidance"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy